← Back to Search

Viscosupplementation

Durolane SJ for Osteoarthritis

Phase 4
Waitlist Available
Led By Alistair Younger, MD
Research Sponsored by Bioventus LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 26 weeks
Awards & highlights

Study Summary

26 week open label study of treatment with Durolane for OA pain of the ankle

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AOS pain subscale score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Durolane SJExperimental Treatment1 Intervention
Durolane SJ intra-articular injection; device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Durolane SJ
2013
N/A
~40

Find a Location

Who is running the clinical trial?

Bioventus LLCLead Sponsor
16 Previous Clinical Trials
15,211 Total Patients Enrolled
10 Trials studying Osteoarthritis
1,698 Patients Enrolled for Osteoarthritis
Alistair Younger, MDPrincipal InvestigatorSt. Pauls Hospital
1 Previous Clinical Trials
100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025